Ijraset Journal For Research in Applied Science and Engineering Technology
Authors: Mr. Bite Rushikesh Vishwanath, Prof. Bagwan L. R., Dr. Hingane L. D.
DOI Link: https://doi.org/10.22214/ijraset.2021.39526
Certificate: View Certificate
Headache is an extremely common symptom and collectively headache disorders are among the most common of the nervous system disorders, with a prevalence of 48.9% in the general population.1 Headache affects people of all ages, races and socioeconomic status and is more common in women. Some headaches are extremely debilitating and have significant impact on an individual’s quality of life, imposing huge costs to healthcare and indirectly to the economy in general. Only a small proportion of headache disorders require specialist input. The vast majority can be effectively treated by a primary care physician or generalist with correct clinical diagnosis that requires no special investigation. Primary headache disorders – Headaches, tension headache and cluster headache – constitute nearly 98% of all headaches; however, secondary headaches are important to recognise as they are serious and may be life threatening. This article provides an overview of the most common headache disorders and discusses the red flag symptoms that help identify serious causes that merit urgent specialist referral. The current pathway of headache care in the UK is discussed with a view to proposing a model that might fit well in the financially constrained National Health Service (NHS) and with new NHS reforms. The role of the national society, the British Association for the Study of Headache, and the patient organisations such as Headaches Trust in headache education to the professionals and the general public in shaping headache care in the UK is described. The article concludes by summarising evidence-based management of common headache diagnoses.
I. INTRODUCTION
Headache is a painful disorder of the head sometimes associated with pain of the face and/or neck.
II. HISTORY OF HEADACHE
The history of headache, starting with the earliest records from Mesopotamia, and continuing through Hippocrates, Aerateus, and Galen, provides a glimpse into a malady that has endured through several millenia. In this chapter, we also explore the history of headache treatment from the ancients, through the Middle Ages, and to the end of the 19th century. Finally, we explore the development of the remarkable innovations in pharmaceutical therapies during the late 20th and early 21st centuries.
III. TYPE OF HEADACHES
IV. CAUSES OF HEADACHE
Abrupt cessation of medications that contain caffeine, such as some pain-relieving medications like ibuprofen (Advil) or acetaminophen (Tylenol) weather changes food and drinks, such as chocolate; processed foods that contain monosodium glutamate (MSG); or alcohol Many of those triggers for tension headaches—especially stress, hunger, fatigue, and lack of sleep—can also set off a Headaches headache. But nailing down causes of headaches in the Headaches category is a little trickier; the headaches may stem from many factors, or combinations of factors. The particular combination is specific to an individual. Potential culprits include
Abrupt cessation of medications that contain caffeine, such as some pain-relieving medications like ibuprofen (Advil) or acetaminophen (Tylenol) food additives, such as monosodium glutamate (MSG) and nitrates (found
V. SYMPTOMS OF HEADACHES
The primary symptom of Headaches is a headache. Pain is sometimes described as pounding or throbbing. It can begin as a dull ache that develops into pulsing pain that is mild, moderate or severe. If left untreated, your headache pain will become moderate to severe. Pain can shift from one side of your head to the other, or it can affect the front of your head, the back of your head or feel like it’s affecting your whole head. Some people feel pain around their eye or temple, and sometimes in their face, sinuses, jaw or neck.
A. Other Symptoms of Headaches Include
B. Prodrome Symptoms
C. Aura symptoms: IMG.04 –Other Symptoms
D. Headache Symptoms
E. Postdrome Symptoms
VI. DIAGNOSIS
If you have migraines or a family history of migraines, a doctor trained in treating headaches (neurologist) will likely diagnose migraines based on your medical history, symptoms, and a physical and neurological examination. If your condition is unusual, complex or suddenly becomes severe, tests to rule out other causes for your pain might include Magnetic resonance imaging (MRI). An MRI scan uses a powerful magnetic field and radio waves to produce detailed images of the brain and blood vessels. MRI scans help doctors diagnose tumors, strokes, bleeding in the brain, infections, and other brain and nervous system (neurological) conditions. Computerized tomography (CT) scan. A CT scan uses a series of X-rays to create detailed cross-sectional images of the brain. This helps doctors diagnose tumors, infections, brain damage, bleeding in the brain and other possible medical problems that may be causing headaches.
A. Treatment
Migraine treatment is aimed at stopping symptoms and preventing future attacks.
Many medications have been designed to treat migraines. Medications used to combat migraines fall into two broad categories:
Pain-relieving medications. Also known as acute or abortive treatment, these types of drugs are taken during migraine attacks and are designed to stop symptoms. Preventive medications. These types of drugs are taken regularly, often daily, to reduce the severity or frequency of migraines. Your treatment choices depend on the frequency and severity of your headaches, whether you have nausea and vomiting with your headaches, how disabling your headaches are, and other medical conditions you have.
B. Medications for Relief
Medications used to relieve migraine pain work best when taken at the first sign of an oncoming migraine — as soon as signs and symptoms of a migraine begin. Medications that can be used to treat it include:
Pain relievers. These over-the-counter or prescription pain relievers include aspirin or ibuprofen (Advil, Motrin IB, others). When taken too long, these might cause medication-overuse headaches, and possibly ulcers and bleeding in the gastrointestinal tract.
Migraine relief medications that combine caffeine, aspirin and acetaminophen (Excedrin Migraine) may be helpful, but usually only against mild migraine pain. Triptans. Prescription drugs such as sumatriptan (Imitrex, Tosymra) and rizatriptan (Maxalt, Maxalt-MLT) are used to treat migraine because they block pain pathways in the brain. Taken as pills, shots or nasal sprays, they can relieve many symptoms of migraine. They might not be safe for those at risk of a stroke or heart attack. Dihydroergotamine (D.H.E. 45, Migranal). Available as a nasal spray or injection, this drug is most effective when taken shortly after the start of migraine symptoms for migraines that tend to last longer than 24 hours. Side effects can include worsening of migraine-related vomiting and nausea.
VII. MATERIALS AND METHODS
A. Mustard Oil
2. Uses: Mustard seeds are also effective when you are suffering from headaches and Headachess. The seeds are packed with magnesium that soothes our nerve system and relieves the pain and strain in any different parts of our body.
a. May block microbial growth.
b. May promote skin and hair health.
c. May alleviate pain.
d. May slow cancer cell growth.
e. May support heart health.
f. Reduces inflammation.
g. May help treat cold symptoms.
h. High smoke point
B. Nutmeg
1. History of Nutmeg: By the end of the 12th century, most wealthy and elite Europeans had tried these exotic spices and fell madly in love with them. 1512 Portuguese explorers 'discover' the source of nutmeg and establish themselves on and around the Banda islands, stocking up on mace, nutmeg, and cloves.
2. Uses of Nutmeg: A pinch of this exotic spice powder is used in baking, curries, sweets, beverages like tea and mulled wine. Jaiphal is valued as a potent aphrodisiac, digestive stimulant, essential oil easing the pain associated with headaches and treats common cold, cough and asthma.
C. Clove
2. Uses Of Clove
D. Method
VIII. FORMULATION
A. Procedure
50 gm The Powder of Nutmeg add in minimum 100ml of mustard Oil .
Then well mixed that solution and keep for 15 minutes.
Then in That Herbal Paste add 30 gm of clove Powder and then shake Well.
Then That Herbal paste Keep under the room Temperature.
B. Formulation Table
Sr.No |
Ingredient |
Quantity |
Mode Of Action |
1 |
Mustard Oil |
100 ml |
Antimicrobial properties and mode of action of mustard and cinnamon essential oils and their combination against foodborne bacteria |
2 |
Clove |
30 gm |
antibacterial, antifungal, insecticidal and antioxidant |
3 |
Nutmeg |
50gm |
neurological response, but in large doses, both raw nutmeg Anticholinergic drug |
IX. EVALUATION PARAMETER
A. Physical Evaluation
X. RESULT
Evaluation Parameter |
Result Obtained |
Colors |
Raddish Brown |
Odour |
Pungent Flavor |
PH |
4.1 |
Homogenicity |
Goood |
Irritability |
No irritability |
Stability |
Stable |
Taste |
Pungent Flavor |
Use |
Easy |
XI. DISCUSSION ON HEADACHES
Dr. G. J. V. Crosby: At 6.45 on a fine summer morning last year, I was summoned
urgently to see a middle-aged pharmaceutical chemist who had wakened at 5 a.m. with an intolerable headache. I found him prostrated but fully conscious. He had recently been suffering from headaches which he attributed to his eyes but they had not been serious enough to seek advice and he had doctored himself with reasonable success. This, however, was such a headache as he had never before experienced. He had vomited and the pain had subsided to some degree but was still severe. The pupils were small and reacted sluggishly and he had some rigidity of the neck. Plantar reflexes were doubtful but that on the right side appeared predominantly extensor. The pulse was slow. Obviously there had been an intracranial calamity and a leaking aneurysm seemed a possibility. Unfortunately he did not make the journey to hospital as he suddenly went into epileptiform convulsions, with extreme neck retraction and expired in a matter of minutes. Autopsy that afternoon showed an extensive subarachnoid hiemorrhage. This was the most dramatic instance I could recollect when considering cases of headache occurring in my own practice during the past year or so. But, the comparative rarity of conditions of this type made me feel that here was not a true example of headache in acommonly presenting guise. So f returned to my case book. Here are three more short histories. Some five months ago I was consulted by a man of 45 who complained of severe morning headaches, usually, but not always, unilateral. They had been increasing lately, both in duration and intensity and now lasted regularly twenty-four hours culminating in nausea and vomiting.
Headaches is an extremely prevalent and disabling neurologic disorder that manifests as periodic attacks of severe head pain and is accompanied by associated symptoms of interference with activity, nausea/vomiting, and sensitivity to light and sound. Headaches is a disorder associated with significant psychosocial impact. The diagnosis of Headaches requires a good clinical history, and exclusion of other causes of headache. However, further investigations are needed when the findings from the history and clinical examination are atypical of Headaches, or if there is a recent change in the character of the patient\\\'s headaches. Current pharmaceutical anti-Headaches treatments have revolutionized Headaches management. Optimal treatment needs to be individualized, taking into consideration side effects of medications, duration and severity of symptoms, and outcome of previous treatments.
[1] Woldeamanuel YW, Andreou AP, Cowan RP. Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies. J Neurol Sci 2014;342(1-2):1–15 [2] Herekar AD, Herekar AA, Ahmad A, et al. The burden of headache disorders in Pakistan: methodology of a population-based nationwide study, and questionnaire validation. J Headache Pain 2013;14:73–80 [3] GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Dis¬ease Study 2016. Lancet Neurol 2018;17(11):954–976 [4] American Association for the Study of Headache Interna¬tional Headache Society. Consensus statement on improving migraine management. Headache 1998;38(10):736 [5] Headache Classification Committee of the International Head¬ache Society. Classification and diagnostic criteria for head¬ache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1–96 [6] Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disor¬ders, 3rd edition (beta version). Cephalalgia.2013;33(9):629-808 [7] Vingen JV, Sand T, Stovner LJ. Sensitivity to various stimu¬li in primary headaches: a questionnaire study. Headache 1999;39(8):552–558 [8] Liu-Chen LY, Gillespie SA, Norregaard TV. Moskowitz MA. Co-localization of retrogradely transported wheat germ agglu¬tinin and the putative neurotransmitter substance P within trigeminal ganglion cells projecting to cat middle cerebral artery. J Comp Neurol 1984;225(2):187–192 [9] Arbab MA, Wiklund L, Svendgaard NA. Origin and distribu¬tion of cerebral vascular innervation from superior cervical, trigeminal and spinal ganglia investigated with retrogradeand anterograde WGA-HRP tracing in the rat. Neuroscience 1986;19(3):695–708 [10] Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988;23(2):193–196 [11] Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16(2):157–168 [12] Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28(2):183–187 [13] Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000;20(10):907–918 [14] Edvinsson L, Goadsby PJ. Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia 1995;15(4):272–276 [15] Reuter U, Bolay H, Jansen-Olesen I, et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001;124(Pt 12):2490–2502
Copyright © 2022 Mr. Bite Rushikesh Vishwanath, Prof. Bagwan L. R., Dr. Hingane L. D.. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Paper Id : IJRASET39526
Publish Date : 2021-12-20
ISSN : 2321-9653
Publisher Name : IJRASET
DOI Link : Click Here